PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers identify a new class of 'good' fats

Discovery offers a promising new direction for diabetes prevention and treatment

2014-10-09
(Press-News.org) BOSTON – The surprising discovery of a previously unidentified class of lipid molecules that enhance insulin sensitivity and blood sugar control offers a promising new avenue for the prevention and treatment of type 2 diabetes.

The new findings, made by a team of scientists from Beth Israel Deaconess Medical Center (BIDMC) and the Salk Institute, are described in the October 9 online issue of the journal Cell.

"We were blown away to discover this completely new class of molecules," says senior author Barbara Kahn, MD, Vice Chair of the Department of Medicine at BIDMC and the George R. Minot Professor of Medicine at Harvard Medical School. Named fatty acid hydroxyl fatty acids, or FAHFAs, these new molecules are in fat cells as well as other cells throughout the body. They now join a small group of fatty acids known to benefit health, which also include omega-3 fatty acids found in fish oil.

"Based on their biology, we can add FAHFAs to the small list of beneficial lipids," says co-senior author Alan Saghatelian, PhD, a professor in the Clayton Foundation Laboratories for Peptide Biology at the Salk Institute in La Jolla, Calif. "These lipids are amazing because they can also reduce inflammation, suggesting that we might discover opportunities for these molecules in inflammatory diseases, such as Crohn's disease and rheumatoid arthritis, as well as diabetes."

Unlike omega-3 fatty acids, which are not made in mammals, FAHFAs are actually produced and broken down inside the human body. "This important feature gives FAHFAs an advantage in terms of therapeutic development because we can potentially modify the rate of production and breakdown throughout the body," notes Kahn. "Because we can measure FAHFA levels in blood, low levels may turn out to be an early marker for the risk of developing type 2 diabetes. Consequently, if restoring FAHFA levels in insulin resistant individuals proves to be therapeutic, we may potentially be able to intervene before the development of frank diabetes."

Glut-4 Mouse Model Is Key to Discovery

Key to the new findings was an animal model first created in the Kahn laboratory in the early 1990s. "Our adipose-specific GLUT-4 overexpressing mouse model [AG4OX] was initially designed after we observed that humans who are insulin resistant – and therefore more prone to develop diabetes and metabolic disease – have lower levels of the GLUT-4 glucose transporter molecules in their fat cells," says Kahn. "To our surprise, overexpression of GLUT-4 in fat was sufficient to increase glucose tolerance and protect the mice against diabetes, even when the animals were obese."

Over the years, the investigators have consistently observed that these mice have elevated fatty acids, which is generally associated with insulin resistance and glucose intolerance. But the AG4OX mice are sensitive to insulin and able to control blood sugar.

Therefore, to find out more about these fatty acids, Kahn collaborated with Saghatelian to conduct advanced lipodomic analyses of the AG4OX mice compared to normal littermates.

"Mass spectrometry lipodomics technology enables us to quantify hundreds of lipids from a biological sample by using the molecular weight of a lipid as a means to determine its presence in a cell or tissue," explains Saghatelian. When the investigators examined the lipodomics results, they discovered a group of four lipids that were elevated 16-18-fold in the AG4OX mice, but not in the normal mice. A search of existing lipid databases to learn the identity (i.e. the structure) of these lipids turned up empty, so the investigators set out to further probe these mysterious molecules.

"Once we had the molecular formula from our lipodomics data, we knew that these lipids belonged to a novel family, and we were then able to use tandem mass spectrometry [MS/MS] and chemical synthesis to identify their structures," explains Saghatelian. Through this approach, they discovered that the molecules consisted of a hydroxyl fatty acid and fatty acid that were joined by an ester bond.

"I've been conducting these analyses for more than a decade and FAHFA is one of only two new classes of lipids that we've uncovered," he notes. "This is a rare discovery."

The authors then went on to conduct a series of experiments. They discovered that feeding the mice extra FAHFAs resulted in a rapid and dramatic drop in blood sugar and rise in insulin. They also looked at FAHFA levels in human fat and plasma, studying samples from individuals who were known to be insulin resistant and at high risk for developing diabetes. In this case, FAHFA levels were found to be 50 to 75 percent lower than levels in people with normal insulin sensitivity, suggesting that changes in FAHFA levels might be contributing to diabetes.

The team also identified GPR-120, the cellular receptor that FAHFAs bind to. "When FAHFAs bind to GPR-120, they are able to control how much glucose is taken up into fat cells," says Kahn. "The receptor may also be responsible for the effects of the novel lipids to reduce widespread macrophage activation, which is associated with obesity and with inflammatory diseases.

"The discovery of FAHFAs provides important new insights underlying metabolic and inflammatory diseases, and, of critical importance, offers viable new treatment avenues that we hope to be able to test in clinical trials," says Kahn. "This is of critical importance as rates of obesity and type 2 diabetes remain at epidemic proportions worldwide."

INFORMATION:

In addition to Kahn and Saghatelian, coauthors include BIDMC investigators Mark M. Yore and Ismail Syed (co-first authors), Pedro M. Moraes-Vieira, Mark A. Herman, Jennifer Lee, Odile D. Peroni, and Abha S. Dhaneshwar; Tejia Zhang and Shili Chen of the Salk Institute; Edwin A. Homan of Harvard University; Rajesh Patel and Timothy E. McGraw of Weill Cornell Medical College; and Ann Hammarstedt and Ulf Smith of the University of Gothenburg, Sweden.

This work was supported, in part, by National Institutes of Health grants R37DK43051, P30 DK57521; R01 DK098002. Other funding is from the JPB Foundation, the Searle Scholars Award, Burroughs Wellcome Fund CABS, Sloan Foundation Fellowship, and grants from the Harvard Training Program in Nutrition and Metabolism.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.

BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.



ELSE PRESS RELEASES FROM THIS DATE:

Scientists reveal why beer tastes good to us and to flies

2014-10-09
Beer yeasts produce chemicals that mimic the aroma of fruits in order to attract flies that can transport the yeast cells to new niches, report scientists from VIB, KU Leuven and NERF in the reputed journal Cell Reports. Interestingly, these volatile compounds are also essential for the flavor of beverages such as beer and wine. Kevin Verstrepen (VIB/KU Leuven): "The importance of yeast in beer brewing has long been underestimated. But recent research shows that the choice of a particular yeast strain or variety explains differences in taste between different beers and ...

Set of molecules found to link insulin resistance in the brain to diabetes

2014-10-09
A key mechanism behind diabetes may start in the brain, with early signs of the disease detectable through rising levels of molecules not previously linked to insulin signaling, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai published today in the journal Cell Metabolism. Past studies had found that levels of a key set of protein building blocks, branched-chain amino acids (BCAAs), are higher in obese and diabetic patient, and that this rise occurs many years before someone develops diabetes. Why and how BCAA breakdown may be ...

New computational approach finds gene that drives aggressive brain cancer

New computational approach finds gene that drives aggressive brain cancer
2014-10-09
NEW YORK, NY (October 9, 2014)—Using an innovative algorithm that analyzes gene regulatory and signaling networks, Columbia University Medical Center (CUMC) researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer. The CUMC team demonstrated in mice transplants that these tumors can be suppressed by reintroducing KLHL9 protein, offering a possible strategy for treating this lethal disease. The study was published today in the online issue of Cell. The team used ...

Scientists discover a 'good' fat that fights diabetes

Scientists discover a good fat that fights diabetes
2014-10-09
VIDEO: Salk researchers explain how a new class of lipids may be tied to diabetes. Click here for more information. LA JOLLA—Scientists at the Salk Institute and Beth Israel Deaconess Medical Center (BIDMC) in Boston have discovered a new class of molecules—produced in human and mouse fat—that protects against diabetes. The researchers found that giving this new fat, or lipid, to mice with the equivalent of type 2 diabetes lowered their elevated blood sugar, ...

Long-term treatment success using gene therapy to correct a lethal metabolic disorder

Long-term treatment success using gene therapy to correct a lethal metabolic disorder
2014-10-09
New Rochelle, NY, October 9, 2014—Excessive and often lethal blood levels of bilirubin can result from mutations in a single gene that are the cause of the metabolic disease known as Crigler-Najjar syndrome type 1 (CNS1). A new gene therapy approach to correcting this metabolic error achieved significant, long-lasting reductions in bilirubin levels in a mouse model of CNS1 and is described in an Open Access article in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Human Gene Therapy website at http://online.liebertpub.com/doi/full/10.1089/hum.2013.233. ...

Clove oil tested for weed control in organic Vidalia sweet onion

2014-10-09
TIFTON, GA – Weed control is one of the most challenging aspects of organic crop production. Most growers of certified organic crops rely heavily on proven cultural and mechanical weed control methods while limiting the use of approved herbicides. A new study of herbicides derived from clove oil tested the natural products' effectiveness in controlling weeds in Vidalia® sweet onion crops. "Cultivation with a tine weeder and hand weeding are the primary tools currently used for weed control in organic sweet onion (Allium ceps)," explained scientist W. Carroll ...

Wild tomato species focus of antioxidant study

Wild tomato species focus of antioxidant study
2014-10-09
IZMIR, TURKEY – Tomatoes are known to be rich in antioxidants such as vitamin C, lycopene, β-carotene, and phenolics. Antioxidants, substances capable of delaying or inhibiting oxidation processes caused by free radicals, are of interest to consumers for their health-related contributions, and to plant breeders for their ability to provide plants with natural resistance to biotic and abiotic stresses. While tomato domestication and breeding programs have typically focused on traits such as fruit weight, color, shape, and disease resistance, scientists are now ...

Study examines effect of antibiotic susceptibility for patients with bloodstream infection

2014-10-09
In an analysis of more than 8,000 episodes of Staphylococcus aureus bloodstream infections, there were no significant differences in the risk of death when comparing patients exhibiting less susceptibility to the antibiotic vancomycin to patients with more vancomycin susceptible strains of S. aureus, according to a study published in JAMA. The study is being released early online to coincide with the IDWeek 2014 meeting. Staphylococcus aureus is among the most common causes of health care-associated infection throughout the world. It causes a wide range of infections, ...

Hospitalized children benefit from antibiotic stewardship programs

2014-10-09
PHILADELPHIA – Hospitalized children go home sooner and are less likely to be readmitted when the hospital has an antibiotic stewardship program that's dedicated to controlling antibiotic prescriptions and treatment, according to a study being presented at IDWeek 2014™. The study is the first to show the benefits of such programs on children's health. Antibiotic stewardship programs are increasingly being used to manage how and when antibiotics are being prescribed in hospitals and other health care facilities across the country. Often led by epidemiologists or ...

Chemists uncover new role of a key base in organic synthesis

2014-10-09
An international team of chemists has discovered a new piece to the puzzle of how a powerful base used in organic synthesis, cesium carbonate, plays a pivotal role during a catalytic reaction. The research, published by the Journal of the American Chemical Society, was led by Jamal Musaev, a theoretical chemist at Emory University, and Ken Itami, an experimental chemist from Nagoya University in Japan. Sun Yat-Sen University in Guangzhou, China, also contributed to the findings. Many organic chemistry reactions are acid/base reactions, involving the exchange of positively ...

LAST 30 PRESS RELEASES:

McGill discovery sheds new light on autism, intellectual disabilities

Cellular changes occur even below the hexavalent chromium limit

Study suggests a new way to curb social media’s body image toll

Plant doctor: An AI system that watches over urban trees without touching a leaf

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

[Press-News.org] Researchers identify a new class of 'good' fats
Discovery offers a promising new direction for diabetes prevention and treatment